Xenetic Biosciences, Inc. (XBIO)
Data as of , from SEC Form 4 filings.
See up to 3 months of XBIO. The 7-day demo opens the 1M and 3M ranges and puts XBIO on your watchlist.
Start 7-day demoLatest XBIO insider trades
James F. Parslow - OfficerGrant or award100,000 sh- Alexey Andreevich Vinogradov - DirectorGrant or award2,500 sh
- Firdaus J. Dastoor - Director
About Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. files with the SEC under CIK 0001534525 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
XBIO Form 4 activity by transaction type, last 90 days
No Form 4 activity for XBIO in the last 90 days.
XBIO insider transactions (Form 4)
99 Form 4 filings on record, the earliest from Dec 13, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James F. Parslow - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Alexey Andreevich Vinogradov - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Firdaus J. Dastoor - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Roger D. Kornberg - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Grigory G. Borisenko - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Grigory G. Borisenko - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Firdaus J. Dastoor - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Alexey Andreevich Vinogradov - Director | Grant or award | Stock Options | 2,500 | $0.00 | - | |
| Roger D. Kornberg - Director | Grant or award | Stock Options | 2,500 | $0.00 | - |
XBIO insider trading FAQ
What is the latest insider trade for XBIO?
Xenetic Biosciences, Inc. (XBIO) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-23. The full record for XBIO runs to 9 Form 4 filings, the earliest from 2024-12-13. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XBIO stock?
No insider purchases of XBIO were filed in the last 90 days.
How many insiders are selling XBIO stock?
No insider sales of XBIO were filed in the last 90 days.
Where can I see XBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XBIO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James F. Parslow view on EDGAR
- - Alexey Andreevich Vinogradov view on EDGAR
- - Firdaus J. Dastoor view on EDGAR
- - Roger D. Kornberg view on EDGAR
- - Grigory G. Borisenko view on EDGAR
- - Grigory G. Borisenko view on EDGAR
- - Firdaus J. Dastoor view on EDGAR
- - Alexey Andreevich Vinogradov view on EDGAR
- - Roger D. Kornberg
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where XBIO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XBIO with a 7-day demo
- XBIO on your watchlist
- Every XBIO Form 4 filing on record
- Up to 3 months of XBIO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
